TGFB3 and metabolic dysfunction-associated steatotic liver disease: In individuals who developed the disease (25.3% of the study population, 334/1322), TGF-β3 levels were significantly elevated in 2009, highlighting the role of the cytokine as a potential predictor of NAFLD development [49].